Weekly Digest – April 2025 Weekly Digest – April 2025 09 Apr 2025: OS Therapies completes acquisition of Advaxis Immunotherapies clinical, pre-clinical and IP assets from Ayala Pharmaceuticals OS Therapies (NYSE-A: OSTX) has completed the acquisition of listeria-based cancer immunotherapy […]